HIGHLIGHTS
- who: Pyrazoline and colleagues from the Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, Istanbul, Turkey have published the research: Acta Chim. Slov. 2022, 69, 293-303 Tok et al.: Design, Synthesis, In Silico ADMET Studies .., in the Journal: (JOURNAL)
- what: The authors report the synthesis of 2-pyrazolines starting from 1-(benz [1,3]dioxol-5-yl)ethanone and further evaluated their anticancer activities on HeLa (human cervical adenocarcinoma), MCF7 (human breast adenocarcinoma) cancer cells. In this study, data were collected from 3 different biological replicates and the results were plotted as mean . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.